Catheter Precision Completes 80% Acquisition of Flyte
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 10 2026
0mins
Source: stocktwits
- Acquisition Completed: Catheter Precision completed its acquisition of an 80% stake in Flyte on Tuesday, significantly increasing its market share in the rapidly growing private aviation sector, which led to a 50% surge in its stock price.
- Capital Inflow: As part of the transaction, Creatd will receive approximately $6 million in cash and $6 million in convertible preferred stock, making it a significant shareholder in VTAK and laying the groundwork for future collaboration.
- Financing Plan: Earlier this month, Catheter Precision signed a securities purchase agreement to raise about $1.9 million through a private placement, with proceeds aimed at working capital, restructuring, and reducing expenses, indicating proactive financial management.
- Market Reaction: Following the acquisition announcement, retail sentiment for VTAK on Stocktwits flipped from 'bearish' to 'extremely bullish', with investors anticipating a price increase to $3, reflecting strong market confidence in the company's future prospects.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy VTAK?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on VTAK
About VTAK
Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. Its two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is also a technology-enabled regional air mobility company.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Flyte Makes Strategic Investment in Volato Group
- Investment Overview: Flyte, the regional air mobility subsidiary of Catheter Precision, Inc., announced the acquisition of approximately 2.9 million shares of Volato Group, Inc., resulting in a 7.5% ownership stake aimed at enhancing accessibility and flexibility in private aviation.
- Collaboration Potential: This investment lays the groundwork for future collaboration, as the strategic relationship between Flyte and Volato is expected to improve service efficiency and innovation, thereby creating long-term shareholder value for both companies.
- Market Expansion Strategy: Flyte's investment supports its strategy to expand its aviation ecosystem, aiming to drive business growth and enhance its AI platform capabilities through partnerships within the industry.
- Shareholder Value Enhancement: Volato's CEO noted that this investment not only provides growth capital but also introduces a highly aligned strategic shareholder, which is anticipated to unlock more collaborative opportunities for shareholders.
See More
Volato Group Secures $2.2M Strategic Investment
- Strategic Investment Agreement: Volato Group has signed a definitive agreement for a $2.2 million strategic equity investment led by Catheter Precision, significantly strengthening its balance sheet following the termination of its deal with M2i Global.
- Core Strategic Shift: The capital injection will support Volato's strategic pivot towards the artificial intelligence ecosystem, specifically targeting potential mergers and acquisitions in AI software, data infrastructure, compute, and power generation sectors, indicating a proactive approach to future growth.
- Acquisition Letters of Intent: Volato has received two unsolicited, non-binding letters of intent regarding potential transactions involving AI data center infrastructure and dedicated power generation assets, reflecting market recognition of its strategic direction and potentially accelerating its expansion in the AI sector.
- Shareholder Structure Change: Following this investment, Catheter Precision becomes Volato's largest shareholder, further solidifying its critical role in the company's strategic development, while the investment remains subject to customary closing conditions from NYSE American.
See More
Volato Secures $2.2 Million Strategic Investment to Shift Focus to AI
- Strategic Investment Background: Volato announced a $2.2 million strategic investment aimed at strengthening its balance sheet and refocusing on artificial intelligence, led by Catheter Precision, marking a pivot from an unsuccessful critical minerals merger to pursuing AI infrastructure opportunities.
- Impact of Deal Termination: This investment follows the termination of Volato's transaction with M2i Global, which would have transformed the company into a critical and strategic mineral reserve play, with management believing this shift aligns better with the company's technology assets and long-term shareholder value.
- Market Opportunity Validation: Volato received two unsolicited, non-binding letters of intent related to potential deals within the AI ecosystem, including AI data center infrastructure and power generation assets supporting AI workloads; although no agreements have been reached, management views this as validation of its AI pivot.
- Market Reaction: Despite Volato's stock dropping 23% in premarket trading on Monday, retail sentiment on Stocktwits remains 'extremely bullish', indicating strong market interest in the company's future AI strategy, even as its stock has declined over 45% this year.
See More
Volato Secures $2.2 Million Strategic Investment to Enhance AI Focus
- Strategic Investment Strengthens Finances: Volato Group has signed a $2.2 million investment agreement led by Catheter Precision and other institutional investors, which will enhance Volato's balance sheet and support its strategic pivot towards artificial intelligence.
- Acquisition Opportunity Evaluation: This investment will enable Volato to assess potential acquisition and merger opportunities related to AI infrastructure, software, and data, although no definitive agreements have been executed, management believes these opportunities will enhance long-term shareholder value.
- Shift in Market Focus: Following the termination of the transaction with M2i Global, Volato is refocusing on market opportunities more closely aligned with its technology assets, with the CEO stating that this move will strengthen the company's market positioning and shareholder value.
- Expansion in AI Ecosystem: Volato is currently evaluating unsolicited non-binding letters of intent related to AI data center infrastructure and power generation assets supporting AI workloads, indicating the company's broad opportunities in the rapidly evolving AI sector.
See More
Catheter Precision Reports 200% Revenue Growth in Q1
- Significant Revenue Growth: Catheter Precision's Q1 revenue surged 200% year-over-year to $432,000, up from $143,000 in Q1 2025, driven by strong performance in both its core medical device segment and newly launched aviation platform, indicating robust future growth potential.
- Reduced Net Loss: The company's net loss for Q1 2025 decreased to $1.7 million from $4.0 million in Q1 2025, reflecting significant progress in cost control and operational efficiency, which enhances investor confidence.
- Strategic Acquisition: Creatd sold its remaining stake in Fly Flyte to Catheter Precision for approximately $12 million in cash and equity, further strengthening Catheter Precision's market position in the aviation sector and supporting its diversification strategy.
- Optimistic Market Outlook: With improvements in revenue and net loss, Catheter Precision's dual focus on the medical device and aviation markets is expected to provide strong support for future growth, likely attracting increased investor interest.
See More
Flyte Expands Flight Capacity and Launches Hiring Initiative Following Spirit Airlines Shutdown
- Flight Capacity Increase: Flyte announced an increase in flight capacity following the shutdown of Spirit Airlines, planning to expand its Vision Jet fleet to meet rising domestic route demand, which is expected to enhance service availability and improve customer experience.
- Hiring Initiative Launched: Flyte has initiated a hiring program targeting pilots and aviation professionals affected by Spirit Airlines' exit, providing a structured onboarding and training pipeline to help industry talent transition smoothly into Flyte's operations.
- Market Response Analysis: The shutdown of Spirit Airlines has impacted approximately 17,000 employees, and Flyte anticipates attracting some displaced customers seeking short-haul travel alternatives, which may lead to higher fares and increased interest in alternative travel options.
- Strategic Expansion Direction: Flyte's expansion plans align with its existing growth strategy, aiming to optimize regional route coverage and enhance fleet utilization, thereby solidifying its competitive position in high-demand short-haul markets.
See More
Flyte Makes Strategic Investment in Volato Group
- Investment Overview: Flyte, the regional air mobility subsidiary of Catheter Precision, Inc., announced the acquisition of approximately 2.9 million shares of Volato Group, Inc., resulting in a 7.5% ownership stake aimed at enhancing accessibility and flexibility in private aviation.
- Collaboration Potential: This investment lays the groundwork for future collaboration, as the strategic relationship between Flyte and Volato is expected to improve service efficiency and innovation, thereby creating long-term shareholder value for both companies.
- Market Expansion Strategy: Flyte's investment supports its strategy to expand its aviation ecosystem, aiming to drive business growth and enhance its AI platform capabilities through partnerships within the industry.
- Shareholder Value Enhancement: Volato's CEO noted that this investment not only provides growth capital but also introduces a highly aligned strategic shareholder, which is anticipated to unlock more collaborative opportunities for shareholders.
See More
Volato Group Secures $2.2M Strategic Investment
- Strategic Investment Agreement: Volato Group has signed a definitive agreement for a $2.2 million strategic equity investment led by Catheter Precision, significantly strengthening its balance sheet following the termination of its deal with M2i Global.
- Core Strategic Shift: The capital injection will support Volato's strategic pivot towards the artificial intelligence ecosystem, specifically targeting potential mergers and acquisitions in AI software, data infrastructure, compute, and power generation sectors, indicating a proactive approach to future growth.
- Acquisition Letters of Intent: Volato has received two unsolicited, non-binding letters of intent regarding potential transactions involving AI data center infrastructure and dedicated power generation assets, reflecting market recognition of its strategic direction and potentially accelerating its expansion in the AI sector.
- Shareholder Structure Change: Following this investment, Catheter Precision becomes Volato's largest shareholder, further solidifying its critical role in the company's strategic development, while the investment remains subject to customary closing conditions from NYSE American.
See More
Volato Secures $2.2 Million Strategic Investment to Shift Focus to AI
- Strategic Investment Background: Volato announced a $2.2 million strategic investment aimed at strengthening its balance sheet and refocusing on artificial intelligence, led by Catheter Precision, marking a pivot from an unsuccessful critical minerals merger to pursuing AI infrastructure opportunities.
- Impact of Deal Termination: This investment follows the termination of Volato's transaction with M2i Global, which would have transformed the company into a critical and strategic mineral reserve play, with management believing this shift aligns better with the company's technology assets and long-term shareholder value.
- Market Opportunity Validation: Volato received two unsolicited, non-binding letters of intent related to potential deals within the AI ecosystem, including AI data center infrastructure and power generation assets supporting AI workloads; although no agreements have been reached, management views this as validation of its AI pivot.
- Market Reaction: Despite Volato's stock dropping 23% in premarket trading on Monday, retail sentiment on Stocktwits remains 'extremely bullish', indicating strong market interest in the company's future AI strategy, even as its stock has declined over 45% this year.
See More
Volato Secures $2.2 Million Strategic Investment to Enhance AI Focus
- Strategic Investment Strengthens Finances: Volato Group has signed a $2.2 million investment agreement led by Catheter Precision and other institutional investors, which will enhance Volato's balance sheet and support its strategic pivot towards artificial intelligence.
- Acquisition Opportunity Evaluation: This investment will enable Volato to assess potential acquisition and merger opportunities related to AI infrastructure, software, and data, although no definitive agreements have been executed, management believes these opportunities will enhance long-term shareholder value.
- Shift in Market Focus: Following the termination of the transaction with M2i Global, Volato is refocusing on market opportunities more closely aligned with its technology assets, with the CEO stating that this move will strengthen the company's market positioning and shareholder value.
- Expansion in AI Ecosystem: Volato is currently evaluating unsolicited non-binding letters of intent related to AI data center infrastructure and power generation assets supporting AI workloads, indicating the company's broad opportunities in the rapidly evolving AI sector.
See More
Catheter Precision Reports 200% Revenue Growth in Q1
- Significant Revenue Growth: Catheter Precision's Q1 revenue surged 200% year-over-year to $432,000, up from $143,000 in Q1 2025, driven by strong performance in both its core medical device segment and newly launched aviation platform, indicating robust future growth potential.
- Reduced Net Loss: The company's net loss for Q1 2025 decreased to $1.7 million from $4.0 million in Q1 2025, reflecting significant progress in cost control and operational efficiency, which enhances investor confidence.
- Strategic Acquisition: Creatd sold its remaining stake in Fly Flyte to Catheter Precision for approximately $12 million in cash and equity, further strengthening Catheter Precision's market position in the aviation sector and supporting its diversification strategy.
- Optimistic Market Outlook: With improvements in revenue and net loss, Catheter Precision's dual focus on the medical device and aviation markets is expected to provide strong support for future growth, likely attracting increased investor interest.
See More
Flyte Expands Flight Capacity and Launches Hiring Initiative Following Spirit Airlines Shutdown
- Flight Capacity Increase: Flyte announced an increase in flight capacity following the shutdown of Spirit Airlines, planning to expand its Vision Jet fleet to meet rising domestic route demand, which is expected to enhance service availability and improve customer experience.
- Hiring Initiative Launched: Flyte has initiated a hiring program targeting pilots and aviation professionals affected by Spirit Airlines' exit, providing a structured onboarding and training pipeline to help industry talent transition smoothly into Flyte's operations.
- Market Response Analysis: The shutdown of Spirit Airlines has impacted approximately 17,000 employees, and Flyte anticipates attracting some displaced customers seeking short-haul travel alternatives, which may lead to higher fares and increased interest in alternative travel options.
- Strategic Expansion Direction: Flyte's expansion plans align with its existing growth strategy, aiming to optimize regional route coverage and enhance fleet utilization, thereby solidifying its competitive position in high-demand short-haul markets.
See More
